Study: Very Late Outcomes After PCI Often Occur Far From Original Lesion
A large analysis shows that beyond the first year, adverse events continue to accrue at a rate of approximately 2% per year for up to 5 years after PCI, whether with bare-metal stents or first- or second-generation drug-eluting stents.
An analysis of patient-level data from 19 randomized trials of metallic drug-eluting stents (DES) found that very late stent-related ischemic events continued to accrue at a rate of approximately 2% per year between 1 and 5 years after percutaneous coronary intervention (PCI).